Manufacturing - Generics

Keensight Capital-backed Inke, a Spain-based global manufacturer of inhalation APIs and Highly Potent APIs (HPAPIs), has acquired Pharmanoid, a manufacturing site specialising in the...

Nasdaq-listed Alvotech, an Iceland-headquartered global biotech company specialising in biosimilars, has placed US$108m 6.875% senior unsecured convertible bonds due 2030. The initial conversion price...

Frankfurt-listed life science company Evotec has agreed to sell Just – Evotec Biologics Toulouse site to SIX-listed global generic and biosimilars company, Sandoz. The proposed...

Czechia-based Zentiva, a European generics pharmaceutical company, has changed hands between Advent and GTCR – two global PE firms. The sale - for a...

Belgium-based A.forall, a pharmaceutical group that distributes EU-sourced pharmaceuticals to wholesalers and hospitals, has acquired Provepharm’s US generics portfolio. Provepharm is a France-based independent,...

Fresenius, a Germany-based global healthcare company, is receiving a new €400m (US$470m) loan from the European Investment Bank (EIB) to strengthen Fresenius’ European R&D...

International private equity firms, Bain Capital and Cinven, have signed a definitive agreement to sell a majority stake in STADA Arzneimittel, a healthcare and...

Orifarm, a Denmark-based supplier of pharmaceuticals to wholesalers, pharmacies, hospitals, and patients, has appointed Nicki Lund Kristensen as CFO and Kenneth Svendsen joins as...

BC Partners, a European investment firm, has entered into exclusive negotiations with France-headquartered Servier, an international pharmaceutical company, for the acquisition of Biogaran, one...

EQT is set to acquire a majority stake in Malta-based global pharmaceutical company Adalvo from Iceland-based healthcare private equity investor Aztiq led by Robert...